Navigation Links
Patheon to Present Multiple Scientific Findings at AAPS Annual Meeting and Exposition
Date:11/7/2013

(PRWEB) November 07, 2013

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, will have more than 16 posters and several presentations at the AAPS Annual Meeting and Exposition taking place in San Antonio, Texas, November 10-14, 2013.

Dr. Kane will be making a presentation to the Recent Advances in Fixed-Dose Combination Therapy Symposium. Director of Global Technical Affairs, Dr. Stephen Closs will be making a presentation at the From Particle Engineering to Powder Processing Symposium. In addition, other top scientists from Patheon will be presenting 16 scientific posters. According to Dr. Kane, “Patheon is pleased to share our scientific experience and demonstrate our expertise across areas as diverse as particle engineering, material properties and techniques for solubility enhancement, roller compaction and tableting, taste masking, multiparticulates, softgels and fixed dose combinations.”

A complete listing of all posters Patheon will be presenting at AAPS can be read below and by visiting http://www.patheon.com/marketing/AAPS2013_schedule/index.html.

Multiparticulate Based Drug Delivery to Achieve Zero Order Release
by Abhijit Gokhale, Thomas Williams and Jason Vaughn

Protection of Gelatin Capsule from Cracking through Environmental Relative Humidity Control
by Haibo Wang, Edgar Jaynes, Jeff Moore, Jason Vaughn and Chris Howell

Taste Masking and Solubility Enhancement of an Orally Disintegrating Tablet Containing a Hydrophobic Drug by Inclusion Complex Technique
by Arasu Kondappan, Venkata S. Rao Voleti, Don Barbieri and Jason Vaughn

Predictive Analytical Techniques to Assess Physical Stability of Liposome Based Formulations
by Enrico Corona

Effect of Die Hardness on Compression Tooling Performance to Produce Quality Tablets During High Speed Compression
by Vikram Senjalia and Francois Berthier

An Evaluation of the Capabilities of Liquid Chromatography – Diode Array Detection (LC-DAD) and Liquid Chromatography – Mass Spectrometry (LC-MS) to Detect Co-eluting Related Compound in Pharmaceutical Samples
by Geoff Carr, John Wang, Bharat Joshi, Senaka Ranaweera and Heng Yao

Knowledge Space Transfer using Small Scale Process Design to Facilitate Commercialization of a Roller Compaction Process
by Catarina Terra and Stephen Closs

Formulation Strategies to Optimize Performance of a Poorly Soluble Drug to Achieve Enhanced Solubility with Modified Release Properties
by Saujanya Gosangari, Tatyana Dyakonov and Rishi Thakur

Formulation and Evaluation of Self Micro Emulsifying Progesterone Dosage Forms for Vaginal Delivery
by Sunil Agnihotri, George Vamvakas and Tatyana Dyakonov

Progesterone Stability in Human Hepatocytes
by Peijin Zhang and Aqeel Fatmi

Fill Compositions for Extended Release Softgel Capsules
by Yunhua Hu

Assay and Identification of Mebeverine HCI Contained in a Formulation with Simethicone in Softgels by Liquid Chromatography
by Eduardo Rodrigues and Edith Ortega

Impact in the Rheological Stability of a Formulation in Soft Gelatin Capsule Containing Paracetamol (500 mg) and Hyoscine Butylbromide (10 mg) by Modifying the Kind of Suspensor Agent
by Marisol Martinez

About AAPS
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific association of approximately 11,000 members employed in industry, academia, government, and other research institutes worldwide. The AAPS Annual Meeting and Exhibition is a dynamic international forum where scientists, the media and the public can increase their understanding of the issues, advancements and opportunities facing public health today. For more information visit http://www.AAPS.org.

About Patheon
Patheon Inc. (TSX: PTI) is a leading provider of high-quality contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid, sterile and softgel dosage forms. The company serves approximately 300 of the world’s leading pharmaceutical and biotechnology companies through an integrated network of 12 commercial manufacturing facilities and 9 product development centers across North America and Europe. Patheon enables customers to launch products with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11309612.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patheon’s Michael Lehmann Named Among PharmaVOICE 100 List of Most Inspiring People in Life Sciences Industry
2. Patheon to Host Complimentary Seminar on “Robustness, Reproducibility and Risk Management; the Route to Successful Commercialisation” at Patheon Bourgoin-Jallieu site
3. Targeted therapeutics for colon cancer to be presented at AACR meeting
4. NYU Langone experts present research, clinical advances at neurosurgeons meeting
5. Specific inhibition of autophagy may represent a new concept for treatment of kidney cancer
6. Presidential Recognition Awards presented during the 2012 AIUM Annual Convention
7. Presentation of 1-year IVAN and 2-year CATT study results
8. Kessler Foundation researchers present at first International Congress on Cognition in MS
9. Protein may represent a switch to turn off B cell lymphoma
10. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
11. Mount Sinai presents treatment trends, vaccine research, prognosis data at ASCO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
Breaking Medicine Technology: